Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription Articles published in Infect Immun Retrieve available abstracts of 39 articles: HTML format Text format

Single Articles

July 2018
1. BOEHM DT, Hall JM, Wong TY, DiVenere A, et al
   Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines using a Bordetella pertussis challenge model in mice.
   Infect Immun. 2018 Jul 16. pii: IAI.00857-17. doi: 10.1128/IAI.00857.
   PubMed     Text format     Abstract available
   
   
   
2. ATCHESON E, Bauza K, Salman AM, Alves E, et al
   Tailoring a P. vivax vaccine to enhance efficacy through a combination of a CSP Virus-Like Particle Rv21 and TRAP viral vectors.
   Infect Immun. 2018 Jul 9. pii: IAI.00114-18. doi: 10.1128/IAI.00114.
   PubMed     Text format     Abstract available
   
   
   
3. BELDE V, Cravens M, Gulandijany D, Walker JA, et al
   Terminal deoxynucleotidyl Transferase is not required for antibody response to polysaccharide vaccines against Streptococcus pneumoniae and Salmonella Typhi.
   Infect Immun. 2018 Jul 2. pii: IAI.00211-18. doi: 10.1128/IAI.00211.
   PubMed     Text format     Abstract available
   
   
   April 2018
4. STYLIANOU E, Harrington-Kandt R, Beglov J, Bull N, et al
   Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate TB Subunit Vaccine.
   Infect Immun. 2018 Apr 16. pii: IAI.00014-18. doi: 10.1128/IAI.00014.
   PubMed     Text format     Abstract available
   
   
   
5. QUEMENEUR L, Petiot N, Arnaud-Barbe N, Hessler C, et al
   Clostridium difficile toxoid vaccine candidate confers broad protection against a range of prevalent circulating strains in a non-clinical setting.
   Infect Immun. 2018 Apr 9. pii: IAI.00742-17. doi: 10.1128/IAI.00742.
   PubMed     Text format     Abstract available
   
   
   
6. YU J, Li B, Chen X, Lu J, et al
   Comparison of immunogenicity and protection of two pneumococal protein vaccines based on PsaA and PspA.
   Infect Immun. 2018 Apr 2. pii: IAI.00916-17. doi: 10.1128/IAI.00916.
   PubMed     Text format     Abstract available
   
   
   March 2018
7. SERRADELL MC, Gargantini PR, Saura A, Oms SR, et al
   Cytokines, antibodies and histopathological profiles during Giardia infection and VSP-based vaccination.
   Infect Immun. 2018 Mar 19. pii: IAI.00773-17. doi: 10.1128/IAI.00773.
   PubMed     Text format     Abstract available
   
   
   February 2018
8. OLSEN RW, Ecklu-Mensah G, Bengtsson A, Ofori MF, et al
   Natural and vaccine-induced acquisition of cross-reactive IgG inhibiting ICAM-1-specific binding of a PfEMP1 subtype associated specifically with cerebral malaria.
   Infect Immun. 2018 Feb 5. pii: IAI.00622-17. doi: 10.1128/IAI.00622.
   PubMed     Text format     Abstract available
   
   
   January 2018
9. JONES K, Versteeg L, Damania A, Keegan B, et al
   Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease.
   Infect Immun. 2018 Jan 8. pii: IAI.00876-17. doi: 10.1128/IAI.00876.
   PubMed     Text format     Abstract available
   
   
   
10. MARTINEZ-BECERRA FJ, Kumar P, Vishwakarma V, Kim JH, et al
    Characterization and protective efficacy of type three secretion proteins as a broadly protective subunit vaccine against Salmonella enterica serovars.
    Infect Immun. 2018 Jan 8. pii: IAI.00473-17. doi: 10.1128/IAI.00473.
    PubMed     Text format     Abstract available
    
    
    December 2017
11. BROCKMEIER SL, Loving CL, Nicholson TL, Wang J, et al
    Use of proteins identified through a functional genomic screen to develop a protein subunit vaccine that provides significant protection against virulent Streptococcus suis in pigs.
    Infect Immun. 2017 Dec 4. pii: IAI.00559-17. doi: 10.1128/IAI.00559.
    PubMed     Text format     Abstract available
    
    
    
12. PEREZ AC, Johnson A, Chen Z, Wilding GE, et al
    Mapping protective regions on a three-dimensional model of the Moraxella catarrhalis vaccine antigen, Oligopeptide Permease A.
    Infect Immun. 2017 Dec 4. pii: IAI.00652-17. doi: 10.1128/IAI.00652.
    PubMed     Text format     Abstract available
    
    
    
13. LADDY DJ, Bonavia A, Hanekom WA, Kaushal D, et al
    Toward Tuberculosis Vaccine Development: Recommendations for NHP Study Design.
    Infect Immun. 2017 Dec 4. pii: IAI.00776-17. doi: 10.1128/IAI.00776.
    PubMed     Text format     Abstract available
    
    
    November 2017
14. WANG L, Zhu C, Zhang T, Tian Q, et al
    Non-pathogenic colonization with Chlamydia in the gastrointestinal tract as oral vaccination for inducing transmucosal protection.
    Infect Immun. 2017 Nov 13. pii: IAI.00630-17. doi: 10.1128/IAI.00630.
    PubMed     Text format     Abstract available
    
    
    
15. BURTNICK MN, Shaffer TL, Ross BN, Muruato LA, et al
    Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis.
    Infect Immun. 2017 Nov 6. pii: IAI.00724-17. doi: 10.1128/IAI.00724.
    PubMed     Text format     Abstract available
    
    
    October 2017
16. PAL S, Tifrea DF, Zhong G, de la Maza LM, et al
    Transcervical inoculation with Chlamydia trachomatis induces infertility in HLA-DR4-transgenic and wild type mice.
    Infect Immun. 2017 Oct 16. pii: IAI.00722-17. doi: 10.1128/IAI.00722.
    PubMed     Text format     Abstract available
    
    
    
17. PARZYCH EM, Miura K, Ramanathan A, Long CA, et al
    Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.
    Infect Immun. 2017 Oct 9. pii: IAI.00486-17. doi: 10.1128/IAI.00486.
    PubMed     Text format     Abstract available
    
    
    September 2017
18. LACEY KA, Leech JM, Lalor SJ, McCormack N, et al
    The Staphylococcus aureus cell wall-anchored protein clumping factor A is an important T cell antigen.
    Infect Immun. 2017 Sep 25. pii: IAI.00549-17. doi: 10.1128/IAI.00549.
    PubMed     Text format     Abstract available
    
    
    
19. SEVASTSYANOVICH YR, Withers DR, Marriott CL, Morris FC, et al
    Antigen localisation influences the magnitude and kinetics of the endogenous adaptive immune response to recombinant Salmonella vaccines.
    Infect Immun. 2017 Sep 11. pii: IAI.00593-17. doi: 10.1128/IAI.00593.
    PubMed     Text format     Abstract available
    
    
    July 2017
20. LAVENDER H, Poncin K, Tang CM
    Neisseria cinerea expresses a functional factor H binding protein which is recognised by immune responses elicited by meningococcal vaccines.
    Infect Immun. 2017 Jul 24. pii: IAI.00305-17. doi: 10.1128/IAI.00305.
    PubMed     Text format     Abstract available
    
    
    
21. KUIPERS K, Jong WSP, van der Gaast-de Jongh CE, Houben D, et al
    Th17-mediated cross protection against pneumococcal carriage by vaccination with a variable antigen.
    Infect Immun. 2017 Jul 17. pii: IAI.00281-17. doi: 10.1128/IAI.00281.
    PubMed     Text format     Abstract available
    
    
    
22. KONDURI V, Halpert MM, Liang D, Levitt JM, et al
    Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy.
    Infect Immun. 2017 Jul 3. pii: IAI.00127-17. doi: 10.1128/IAI.00127.
    PubMed     Text format     Abstract available
    
    
    June 2017
23. JIA Q, Dillon BJ, Maslesa-Galic S, Horwitz MA, et al
    Listeria-vectored vaccine expressing the Mycobacterium tuberculosis 30 kDa major secretory protein via the constitutively active prfA* regulon boosts BCG efficacy against tuberculosis.
    Infect Immun. 2017 Jun 19. pii: IAI.00245-17. doi: 10.1128/IAI.00245.
    PubMed     Text format     Abstract available
    
    
    April 2017
24. RAJA AI, Stanisic DI, Good MF
    Chemical attenuation in the development of a whole organism malaria vaccine.
    Infect Immun. 2017 Apr 24. pii: IAI.00062-17. doi: 10.1128/IAI.00062.
    PubMed     Text format     Abstract available
    
    
    March 2017
25. BRENNAN MJ
    The enigmatic PE/PPE Multi-gene Family of Mycobacteria and TB Vaccination.
    Infect Immun. 2017 Mar 27. pii: IAI.00969-16. doi: 10.1128/IAI.00969.
    PubMed     Text format     Abstract available
    
    
    
26. LEES JA, Brouwer M, van der Ende A, Parkhill J, et al
    Within-Host Sampling of a Natural Population Shows Signs of Selection on Pde1 during Bacterial Meningitis.
    Infect Immun. 2017;85.
    PubMed     Text format    
    
    
    February 2017
27. SEMCHENKO EA, Day CJ, Seib KL
    MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.
    Infect Immun. 2017;85.
    PubMed     Text format     Abstract available
    
    
    January 2017
28. GARVY BA
    Overcoming hurdles to vaccine development against Pneumocystis jirovecii.
    Infect Immun. 2017 Jan 23. pii: IAI.00035-17. doi: 10.1128/IAI.00035.
    PubMed     Text format     Abstract available
    
    
    December 2016
29. LONGLEY RJ, Halbroth BR, Salman AM, Ewer KJ, et al
    Assessment of the Plasmodium falciparum pre-erythrocytic antigen UIS3 as a potential candidate for a malaria vaccine.
    Infect Immun. 2016 Dec 28. pii: IAI.00641-16. doi: 10.1128/IAI.00641.
    PubMed     Text format     Abstract available
    
    
    November 2016
30. KHAN MN, Xu Q, Pichichero ME
    Protection against Streptococcus pneumoniae invasive pathogenesis by a protein based vaccine is achieved by suppression of nasopharyngeal bacterial density during Influenza A virus co-infection.
    Infect Immun. 2016 Nov 28. pii: IAI.00530.
    PubMed     Text format     Abstract available
    
    
    
31. ESPINOSA DA, Vega-Rodriguez J, Flores-Garcia Y, Noe AR, et al
    The P. falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Pre-Erythrocytic and Transmission-Blocking Vaccines.
    Infect Immun. 2016 Nov 28. pii: IAI.00498.
    PubMed     Text format     Abstract available
    
    
    October 2016
32. WANG Z, Lazinski DW, Camilli A
    Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.
    Infect Immun. 2016 Oct 24. pii: IAI.00626.
    PubMed     Text format     Abstract available
    
    
    
33. MANCINI S, Menzi C, Oechslin F, Moreillon P, et al
    Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii.
    Infect Immun. 2016 Oct 10. pii: IAI.00810.
    PubMed     Text format     Abstract available
    
    
    September 2016
34. BALDERAS MA, Nguyen C, Terwilliger A, Keitel WA, et al
    Progress Towards the Development of a NEAT Protein Vaccine for Anthrax Disease.
    Infect Immun. 2016 Sep 19. pii: IAI.00755.
    PubMed     Text format     Abstract available
    
    
    August 2016
35. LE MOIGNE V, Belon C, Goulard C, Accard G, et al
    MgtC as a host-induced factor and vaccine candidate against Mycobacterium abscessus infection.
    Infect Immun. 2016 Aug 1. pii: IAI.00359.
    PubMed     Text format     Abstract available
    
    
    June 2016
36. HATCHER CL, Mott TM, Muruato LA, Sbrana E, et al
    Burkholderia mallei CLH001 attenuated vaccine strain is immunogenic and protects against acute respiratory glanders.
    Infect Immun. 2016 Jun 6. pii: IAI.00328.
    PubMed     Text format     Abstract available
    
    
    April 2016
37. GRANT AJ, Oshota O, Chaudhuri RR, Mayho M, et al
    Genes Required for the Fitness of Salmonella enterica Serovar Typhimurium during Infection of Immunodeficient gp91-/- phox Mice.
    Infect Immun. 2016;84:989-97.
    PubMed     Text format     Abstract available
    
    
    February 2016
38. LUJAN E, Pajon R, Granoff DM
    Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.
    Infect Immun. 2015;84:452-8.
    PubMed     Text format     Abstract available
    
    
    January 2016
39. JOHNSON RM, Brunham RC
    Tissue resident T cells as the central paradigm of Chlamydia immunity.
    Infect Immun. 2016 Jan 19. pii: IAI.01378.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: